|Bid||0.3200 x N/A|
|Ask||0.3250 x N/A|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BHSC.CN
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") ") is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol "CNVCF"."Admission to the OTCQB® market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of ...
Purchase order of 1,000 kg for prompt delivery to support the growing demand for VINIA®Pipeline of 6 major customers testing VINIA® for inclusion in their final productsFavorable terms of Purchase Order reflect the increasing value of the product and substantially contribute to BioHarvest's top lineVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") today announced tha
VINIA® sales orders reached a record high of USD 947k representing 99% growth compared to Q2 2021 and 24% growth compared to Q1 2022BioHarvest reiterates guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7MStarted production of VINIA® at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to CannabisApplied for the Cannabis production license in IsraelUnveiled the profile of its unique ...